行情

CGIX

CGIX

CANCER GENETICS
NASDAQ

实时行情|Nasdaq Last Sale

5.44
+1.22
+28.91%
盘后: 5.21 -0.23 -4.23% 16:30 02/20 EST
开盘
5.65
昨收
4.220
最高
5.85
最低
4.600
成交量
67.57万
成交额
--
52周最高
9.89
52周最低
2.003
市值
1,142.29万
市盈率(TTM)
-0.0236
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CGIX 新闻

  • 《消费者报告》首次将特斯拉Model 3列为"首选车型"
  • 新浪美股.6小时前
  • 低利率的大背景下 市政债券或成“新贵”
  • 新浪财经-自媒体综合.7小时前
  • 巴以双方解除农产品贸易禁令
  • 新华网.8小时前
  • 联储二号人物给交易员"泼冷水" 这次市场共识又错了?
  • FX168.8小时前

更多

所属板块

医疗设施与服务
-0.36%
医疗保健提供商与服务
-1.06%

热门股票

名称
价格
涨跌幅

CGIX 简况

Cancer Genetics, Inc. is engaged in the field of personalized medicine, enabling precision medicine in the field of oncology through its diagnostic products and services and molecular markers. Through its subsidiary, the Company offers preclinical test systems. The Company offers discovery services to the pharmaceutical industry, biotechnology companies and academic research centers. The Company provides the tools and testing methods for companies and researchers to identify new molecular- and biomarker-based indicators for disease and to determine the pharmacogenomics, toxicity and efficacy of therapeutic candidate compounds. Its discovery services include development of both xenograft and syngeneic animal models, toxicology and genetic toxicology services, pharmacology testing, pathology services, and validation of biomarkers for diseases including cancers. It also provides consulting, guidance and preparation of samples.
展开

Webull提供Cancer Genetics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。